Maharashtra, India

Prasad Vichare

This inventor holds 2 USPTO granted patents. Top assignees: Piramal Enterprises Limited, Piramal Pharma Limited. Active years: 2021-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Prasad Vichare. Retrieved from https://idiyas.com/inventor/prasad-vichare

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Prasad Vichare: Innovator in SGLT2 Inhibitors

Introduction

Prasad Vichare is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of SGLT2 inhibitors. With a total of two patents to his name, Vichare's work is recognized for its industrial feasibility and economic viability.

Latest Patents

Vichare's latest patents include a process for the preparation of SGLT2 inhibitors and intermediates thereof. This invention relates to an industrially feasible and economically viable process for the preparation of SGLT2 inhibitors of formula X in significantly high yield and purity. Additionally, he has developed a process for the preparation of Bexagliflozin of formula V, which also achieves significantly high yield and purity.

Career Highlights

Throughout his career, Prasad Vichare has worked with prominent companies such as Piramal Pharma Limited and Piramal Enterprises Limited. His experience in these organizations has allowed him to refine his skills and contribute to innovative pharmaceutical solutions.

Collaborations

Some of his notable coworkers include Milind Moreshwar Gharpure and Sanjay Kumar Sharma. Their collaboration has likely fostered an environment of innovation and creativity in their respective projects.

Conclusion

Prasad Vichare's contributions to the field of pharmaceuticals, particularly in the development of SGLT2 inhibitors, highlight his role as an influential inventor. His patents reflect a commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…